ENDOMETRIAL SQUAMOUS METAPLASIA - AN UNUSUAL RESPONSE TO PROGESTIN THERAPY OF HYPERPLASIA

Citation
Mc. Miranda et Mt. Mazur, ENDOMETRIAL SQUAMOUS METAPLASIA - AN UNUSUAL RESPONSE TO PROGESTIN THERAPY OF HYPERPLASIA, Archives of pathology and laboratory medicine, 119(5), 1995, pp. 458-460
Citations number
13
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
Journal title
Archives of pathology and laboratory medicine
ISSN journal
00039985 → ACNP
Volume
119
Issue
5
Year of publication
1995
Pages
458 - 460
Database
ISI
SICI code
0003-9985(1995)119:5<458:ESM-AU>2.0.ZU;2-W
Abstract
Objective.-To report the finding of squamous metaplasia within endomet rial glands occurring as a result of progestin therapy of hyperplasia. Design.-Case series. Retrospective analysis of two cases from 9235 ac cessioned endometrial biopsies. Setting.-Hospital-based pathology labo ratory processing inpatient and outpatient specimens. Patients.-Two wo men, ages 49 and 34 years, with endometrial hyperplasia without squamo us metaplasia who were treated with progestin. Results.-Extensive squa mous metaplasia was found in endometrial glands following progestin th erapy. The posttherapy biopsies also showed progestin-related alterati ons but no evidence of active hyperplasia. Conclusion.-Squamous metapl asia in these eases appears to be a consequence of progestin therapy. The absence of hyperplasia in the progestin-treated endometrium sugges ts that the squamous metaplasia does not represent persistence or prog ression of the original hyperplastic lesion.